Intellia Therapeutics
Get verified emails for Intellia Therapeutics employees
About Intellia Therapeutics
|
|
|
201-500 employees
View all
|
|
Health Care
|
|
Cambridge, Massachusetts
|
|
Intellia Therapeutics was formed in 2014 to lead the industry in one of the most promising new areas of therapeutic development: gene editing and repair using CRISPR-Cas9 technology. Intellia holds exclusive access to one of the most comprehensive intellectual property platforms available for the therapeutic use of CRISPR-Cas9. The company is advancing a broad pipeline toward clinical development, including ex vivo and in vivo approaches. Intellia closed a Series A round in 2014 led by Atlas Venture and Novartis.
|
Intellia Therapeutics Alternatives
Frequently Asked Questions about Intellia Therapeutics
Who are the decision makers in Intellia Therapeutics?
The decision makers in Intellia Therapeutics are Adam Boyd, Amita Joshi, Birgit Schultes, etc. Click to Find Intellia Therapeutics decision makers emails.
Intellia Therapeutics Staff Directory
Search Intellia Therapeutics Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Search Portal
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
